The post Broadcom to pay dividends on March 31; Here’s how much 100 AVGO shares will earn appeared on BitcoinEthereumNews.com. Broadcom’s (NASDAQ: AVGO) next quarterlyThe post Broadcom to pay dividends on March 31; Here’s how much 100 AVGO shares will earn appeared on BitcoinEthereumNews.com. Broadcom’s (NASDAQ: AVGO) next quarterly

Broadcom to pay dividends on March 31; Here’s how much 100 AVGO shares will earn

Broadcom’s (NASDAQ: AVGO) next quarterly dividend is expected on March 27, continuing the company’s sixteen-year payout streak.

More specifically, the American semiconductor giant will reward shareholders with an estimated $0.65 per share next month.

Broadcom dividends. Source: Dividend.com

How much will AVGO shareholders receive in dividends next month?

The next estimated dividend is in line with the previous payout issued on December 31, 2025. In other words, shareholders holding 100 AVGO shares can expect a dividend payment of $65.

As the company has consistently increased its dividends each year since 2010, it is hard to tell what the yearly payout will amount to. 

If the figure remains unchanged, the overall yearly Broadcom dividend will come in at $260.

Broadcom dividends

Compared to some of its competitors, Broadcom’s dividend remains rather appealing, reflecting a balance between returning capital to shareholders and reinvesting in growth. For instance, Nvidia (NASDAQ: NVDA), the semiconductor leader, offers a comparatively symbolic dividend of $0.01 per share.

However, with shares trading around $325 at the time of writing, Broadcom’s forward dividend yield sits near 0.8%, still below the technology sector average of roughly 1.37%. 

AVGO dividend overview. Source: Dividend.com

As mentioned, the AI company pays dividends on a quarterly basis and has increased its payout for no less than sixteen years in a row, signaling a steady emphasis on shareholder returns.

Moreover, the forward payout ratio just north of 18% suggests the dividend remains well covered by earnings, while leaving enough room for further increases while still preserving capital for expansion.

For investors weighing dividend-capture strategies, AVGO stock has historically recovered its typical ex-dividend dip in about 8.6 days on average.

Featured image via Shutterstock

The post Broadcom to pay dividends on March 31; Here’s how much 100 AVGO shares will earn appeared first on Finbold.

Source: https://finbold.com/broadcom-to-pay-dividends-on-march-31-heres-how-much-100-avgo-shares-will-earn/

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0006741
$0.0006741$0.0006741
+0.83%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Federal Reserve Lowers Interest Rates Again

Federal Reserve Lowers Interest Rates Again

The Federal Reserve has made the decision to lower interest rates by 25 basis points, signaling the possibility of further reductions later this year. This move comes as Fed officials appear divided on the future rate path, a divergence not seen in prior economic cycles.Continue Reading:Federal Reserve Lowers Interest Rates Again
Share
Coinstats2025/09/18 02:38
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

Patent strengthens Niagen Bioscience’s intellectual property moat in fast-growing NAD+-boosting IV and injectable delivery formats, supporting commercial expansion
Share
AI Journal2026/02/25 21:36